Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DD-04107 by BCN Peptides for Chronic Urticaria Or Hives: Likelihood of Approval
DD-04107 is under clinical development by BCN Peptides and currently in Phase III for Chronic Urticaria Or Hives. According to...
Data Insights
DD-04107 by BCN Peptides for Pruritus: Likelihood of Approval
DD-04107 is under clinical development by BCN Peptides and currently in Phase III for Pruritus. According to GlobalData, Phase III...